The activity of a new 2-amino-1,3,4-thiadiazole derivative 4ClABT in cancer and normal cells

Folia Histochemica et Cytobiologica

Volumn 49, Issue 3, 2011, Pages 436-444

  Juszczak, Małgorzata ^a   Matysiak, Joanna ^b   Niewiadomy, Andrzej ^b   Rzeski, Wojciech ^a,c  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^c MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

2 amino 1; 3; 4 thiadiazole; Anti cancer activity; Cancer and normal cells; Cell motility; Cell proliferation

Indexed keywords

2 (3 CHLOROPHENYLOAMINO) 5 (2,4 DIHYDROXYPHENYL) 1,3,4 THIADIAZOLE; 2 (4 CHLOROPHENYLAMINO) 5 (2,4 DIHYDROXYPHENYL) 1,3,4 THIADIAZOLE; AMINOTHIADIAZOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA; BREAST CARCINOMA; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG EFFICACY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MACROGLIA; MALIGNANT NEOPLASTIC DISEASE; MEDULLOBLASTOMA; NERVE CELL; NONHUMAN; RAT; RHABDOMYOSARCOMA; SKIN FIBROBLAST; T CELL LEUKEMIA; TERATOMA; THYROID CARCINOMA; TUMOR CELL;

EID: 84856777354     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0062     Document Type: Article

References (31)

1. Siddiqui N, Ahuja P, Ahsan W, Pandeya SN, Alam MS. Thiadiazoles: progress report on biological activities. J Chem Pharm Res. 2009;1:19-30.
2. Ibrahim DA. Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triaolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agent. Eur J Med Chem. 2009;44:2776-2781.
3. Kadi AA, El-Brollosy NR, Al-Deeb OA, Habib EE, Ibrahim TM, El-Emam AA. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4- -oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4- -thiadiazoles. Eur J Med Chem. 2007;42:235-242.
4. - on biological properties. Met Based Drugs. 2002;8:287-291.
5. Chochan ZH. Biologically active Co(II) and NI(II) complexes of N-(2-thienylmethylene)-2-aminothiadiazole. Met Based Drugs. 2002;8:323-327.
6. Talath S, Gadad AK. Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1,3,4]thiadiazole-2- -sulfonyl)-piperazin-1-yl] fluoroquinolonic derivatives. Eur J Med Chem. 2006;4:918-924.
7. Chou JY, Lai SY, Pan SL, Jow GM, Chern JW, Guh JH. Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells. Biochem Pharmacol. 2003;66:115-124.
8. Oettgen HF, Purple JR, Coley VC, Krakoff IH, Burchenal JH. Potentiation of the anti-leucemic effects of 2-aminothiadiazole by isonicotinamide and derivatives. Cancer Res. 1964;24:689-692.
9. Nelson JA, Rose LM, Bennett LL Jr. Effect of 2-amino-1,3,4- -thiadiazole on ribonucleotide pools of leukemia L1210 cells. Cancer Res. 1976;36:1375-1378.
10. Nelson JA, Rose LM, Bennett LL Jr. Mechanism of action 2- -amino-1,3,4-thiadiazole (NSC4728). Cancer Res. 1977;37: 182-187.
11. Hill DL. Aminothiadiazoles. Cancer Chemother Pharmacol. 1980;4:215-220.
12. Lu K, Loo TL. The pharmacologic fate of the antitumor agent 2-amino-1,3,4-thiadiazole in the dog. Cancer Chemother Pharmacol. 1980;4:275-279.
13. Steward JA, Ackerly CC, Myers CF, Newman RA, Krakoff IH. Clinical and clinical pharmacologic studies of 2-amino- 1,3,4-thiadiazole (A-TDA:NSC 4728). Cancer Chemother Pharmacol. 1986;16:287-291.
14. Asbury RF, Wilson J, Blessing JA, Buchsbaum HJ, DiSaia PJ. Aminothiadiazole (NSC4728) in patient with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group. Am J Clin Oncol. 1986;9:334-336.
15. Asbury RF, Blessing JA, Mortel R, Homesley HD, Malfetano J. Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group. Am J Clin Oncol. 1987;10:299-301.
16. Asbury R, Blessing JA, Smith DM, Carson LF. Aminothiadiazole in the treatment of advanced leiomyosarcoma of the uterine corpus. A Gynecologic Oncology Group study. Am J Clin Oncol. 1995;18:397-399.
17. Locker GY, Khandekar J, Krauss S et al. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep. 1987;71:649-650.
18. Asbury RF, Kramar A, Haller DG. Aminothiadiazole (NSC #4728) in patient with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1987;10:380-382.
19. Jung KY, Kim SK, Gao ZG et al. Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists. Bioorg Med Chem. 2004;12:613-623.
20. Gadad AK, Palkar MB, Anand PK, Noolvi MN, Boreddy TS, Wagwade J. Synthesis and biological evaluation of 2-trifluoromethyl/ sulfonamido-5,6-diaryl substituted imidazo[2,1-b]- -1,3,4-thiadiazoles: a novel class of cyclooxygenase-2 inhibitors. Bioorg Med Chem. 2008;16:276-283.
21. Kim KS, Kimball SD, Cai ZW et al. Aminothiadiazole inhibitors of cyclin dependent kinases. United States Patent Application Publication, Pub.No.:US2002/0137778A1.
22. Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors - Part 94. 1,3,4-thiadiazole-2-sulfonamide derivatives as antitumor agents? Eur J Med Chem. 2000;35:867-874.
23. Wu NC, Chiang CH, Lee AR. Studies of carbonic anhydrase inhibitors: physicochemical properties and bioactivities of new thiadiazole derivatives. J Ocul Pharmacol. 1993; 9:97-108.
24. Matysiak J, Opolski A. Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)- 1,3,4-thiadiazoles. Bioorg Med Chem. 2006;14: 4483-4489.
25. Matysiak J. Evaluation of antiproliferative effect in vitro of same 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole derivatives. Chem Pharm Bull. 2006;54:988-991.
26. Matysiak J. Synthesis of 5-Substituted (2,4-dihydroxyphenyl)- -1,3,4-thiadiazole. J Heterocyclic Chem. 2006;43:55-58.
27. Matysiak J, Nasulewicz A, Pełczyńska M, Świtalska M, Jaroszewicz I, Opolski A. Synthesis and antiproliferative activity of same 5-Substituted 2-(2,4-dihydroxyphenyl)-1,3,4- thiadiazoles. Eur J Med Chem. 2006;41:475-482.
28. Rzeski W, Matysiak J, Kandefer-Szerszeń M. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound. Bioorg Med Chem. 2007;15:3201-3207.
29. Juszczak M, Matysiak J, Brzana W, Niewiadomy A, Rzeski W. Evaluation of the antiproliferative activity of 2-(monohalogenophenylamino)- 5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Arzneimittelforschung. 2008;58:353-357.
30. Matysiak J, Niewiadomy A. Application of sulfinylbis(2,4-dihydroxythiobenzoyl) in the synthesis of N-substituted 2-amino- 5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Synth Commun. 2006;36:1621-1630.
31. Litchfield LT Jr, Wilcoxon F. A simplified method of evaluation of dose-effect experiments. J Pharmacol Exp Ther. 1949;96:99-113.